These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 1980697

  • 41. A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine.
    Mellergård M, Lorentzen K, Bech P, Ottosson JO, Rosenberg R.
    Acta Psychiatr Scand Suppl; 1991; 365():28-32. PubMed ID: 1862731
    [Abstract] [Full Text] [Related]

  • 42. Trazodone in the treatment of panic disorder and agoraphobia with panic attacks.
    Mavissakalian M, Perel J, Bowler K, Dealy R.
    Am J Psychiatry; 1987 Jun; 144(6):785-7. PubMed ID: 3296792
    [Abstract] [Full Text] [Related]

  • 43. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    Dunner DL, Ishiki D, Avery DH, Wilson LG, Hyde TS.
    J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
    [Abstract] [Full Text] [Related]

  • 44. Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study.
    Nagy LM, Krystal JH, Woods SW, Charney DS.
    Arch Gen Psychiatry; 1989 Nov; 46(11):993-9. PubMed ID: 2818144
    [Abstract] [Full Text] [Related]

  • 45. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
    Sheehan DV.
    Psychiatr Clin North Am; 1985 Mar; 8(1):49-62. PubMed ID: 2859580
    [Abstract] [Full Text] [Related]

  • 46. Alprazolam for panic disorder and depression.
    Pies R.
    Am J Psychiatry; 1983 May; 140(5):640. PubMed ID: 6133461
    [No Abstract] [Full Text] [Related]

  • 47. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
    Ballenger JC, Burrows GD, DuPont RL, Lesser IM, Noyes R, Pecknold JC, Rifkin A, Swinson RP.
    Arch Gen Psychiatry; 1988 May; 45(5):413-22. PubMed ID: 3282478
    [Abstract] [Full Text] [Related]

  • 48. Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.
    Carr DB, Sheehan DV, Surman OS, Coleman JH, Greenblatt DJ, Heninger GR, Jones KJ, Levine PH, Watkins WD.
    Am J Psychiatry; 1986 Apr; 143(4):483-94. PubMed ID: 2869703
    [Abstract] [Full Text] [Related]

  • 49. Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks.
    Coryell W, Noyes R, Clancy J, Crowe R, Chaudhry D.
    Psychiatry Res; 1985 Aug; 15(4):301-11. PubMed ID: 2866558
    [Abstract] [Full Text] [Related]

  • 50. Fluoxetine in panic disorder.
    Solyom L, Solyom C, Ledwidge B.
    Can J Psychiatry; 1991 Jun; 36(5):378-80. PubMed ID: 1884341
    [Abstract] [Full Text] [Related]

  • 51. Psychopathology of panic attacks in panic disorder.
    Uhlenhuth EH, Leon AC, Matuzas W.
    J Affect Disord; 2006 May; 92(1):55-62. PubMed ID: 16448702
    [Abstract] [Full Text] [Related]

  • 52. The relationship of alprazolam dose to steady-state plasma concentrations.
    Ciraulo DA, Antal EJ, Smith RB, Olson DR, Goldberg DA, Rand EH, Raskin RB, Phillips JP, Shader RI, Greenblatt DJ.
    J Clin Psychopharmacol; 1990 Feb; 10(1):27-32. PubMed ID: 2407754
    [Abstract] [Full Text] [Related]

  • 53. Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness.
    Breier A, Charney DS, Heninger GR.
    Arch Gen Psychiatry; 1986 Nov; 43(11):1029-36. PubMed ID: 3767595
    [Abstract] [Full Text] [Related]

  • 54. Successful use of clonazepam in patients with treatment-resistant panic disorder.
    Tesar GE, Rosenbaum JF.
    J Nerv Ment Dis; 1986 Aug; 174(8):477-82. PubMed ID: 3734770
    [Abstract] [Full Text] [Related]

  • 55. Effect of alprazolam on depression in panic disorder.
    Melvin JA, Lydiard RB, Crowe CM, Laraia MT, Fossey MD, Ballenger JC.
    J Clin Psychopharmacol; 1991 Apr; 11(2):145-6. PubMed ID: 2056142
    [No Abstract] [Full Text] [Related]

  • 56. Biological markers in panic states: lactate-induced panic and mitral valve prolapse.
    Dager SR, Cowley DS, Dunner DL.
    Biol Psychiatry; 1987 Mar; 22(3):339-59. PubMed ID: 2880610
    [Abstract] [Full Text] [Related]

  • 57. Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study.
    Buller R, Maier W, Goldenberg IM, Lavori PW, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 Mar; 240(3):163-8. PubMed ID: 1827602
    [Abstract] [Full Text] [Related]

  • 58. A 15-year follow-up study of patients with panic disorder.
    Andersch S, Hetta J.
    Eur Psychiatry; 2003 Dec; 18(8):401-8. PubMed ID: 14680716
    [Abstract] [Full Text] [Related]

  • 59. Response of panic disorder to fixed doses of alprazolam or imipramine.
    Uhlenhuth EH, Matuzas W, Glass RM, Easton C.
    J Affect Disord; 1989 Dec; 17(3):261-70. PubMed ID: 2529295
    [Abstract] [Full Text] [Related]

  • 60. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Pols H, Verburg K, Hauzer R, Meijer J, Griez E.
    Biol Psychiatry; 1996 Nov 01; 40(9):913-7. PubMed ID: 8896779
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.